New York, NY, August 25, 2009-EbitdaEXTRA reports that negative EBITDA for Imarx Therapeutics, Inc. (OTC:IMRX) for its twelve months ended June 30, 2009 was $(1,254,000), a 86% improvement over the ye ... read full story
Stocks closed today's strong rally following speculation that the European Union will step in to bail out Greece. Germany and its European Union partners are expected to offer Greece and other troubled EU members loan guarantees. Oil climbed almost $ ... read full story
N/A 
